StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report sent to investors on Sunday. The firm issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Performance
Shares of NYSE AMPE opened at $0.29 on Friday. The firm has a 50 day moving average of $1.28 and a 200 day moving average of $1.92. The firm has a market capitalization of $326,040.00, a price-to-earnings ratio of -0.03 and a beta of 1.95. Ampio Pharmaceuticals has a 12-month low of $0.14 and a 12-month high of $8.30.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last announced its earnings results on Wednesday, March 27th. The company reported ($2.48) earnings per share (EPS) for the quarter.
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
See Also
- Five stocks we like better than Ampio Pharmaceuticals
- Learn Technical Analysis Skills to Master the Stock Market
- High-Yield Texas Instruments Could Hit New Highs Soon
- What is a Secondary Public Offering? What Investors Need to Know
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- What Are Trending Stocks? Trending Stocks Explained
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
